FDA Approves Sandoz Biosimilar for Tysabri® | McDonnell Boehnen Hulbert & Berghoff LLP
It was not so long ago that many, including members of Congress, were bemoaning the slow approval and introduction into the marketplace of biosimilar alternatives to (generally...
Source: jdsupra.com